
|Articles|July 15, 2021
Twenty Years of Growth at Frontage Labs
Author(s)Frontage Labs
Trending on PharmExec
1
Novartis Investors Share Concerns Over M&A Strategy: Report
2
The Agentic AI Revolution in Biopharma
3
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
4
Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum
5
